High Tower Advisors, LLC Humacyte, Inc. Transaction History
High Tower Advisors, LLC
- $71.6 Billion
- Q4 2024
A detailed history of High Tower Advisors, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 13,105 shares of HUMA stock, worth $54,385. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,105Holding current value
$54,385% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
161Shares Held
35.8MCall Options Held
284KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$29.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$21 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$19.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$8.47 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$5.26 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $427M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...